Skip to content
GenoLensGenoLens

DLX5

Chr 7q21.3

distal-less homeobox 5

MANE:
ENST00000648378.1

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Fetal anomalies

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Limb disorders

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Monogenic hearing loss

Disease associations (Open Targets)

  • Split hand-split foot malformation

    0.67
  • split hand-foot malformation 1 with sensorineural hearing loss

    0.60
  • Split hand - split foot - deafness

    0.51
  • split hand-foot malformation

    0.37
  • neurodegenerative disease

    0.37
  • male infertility

    0.28
  • smoking initiation

    0.25
  • attention deficit-hyperactivity disorder

    0.21
  • substance abuse

    0.21
  • hereditary disease

    0.19

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Homeobox protein DLX-5

Transcriptional factor involved in bone development. Acts as an immediate early BMP-responsive transcriptional activator essential for osteoblast differentiation. Stimulates ALPL promoter activity in a RUNX2-independent manner during osteoblast differentiation. Stimulates SP7 promoter activity during osteoblast differentiation. Promotes cell proliferation by up-regulating MYC promoter activity. Involved as a positive regulator of both chondrogenesis and chondrocyte hypertrophy in the endochondral skeleton. Binds to the homeodomain-response element of the ALPL and SP7 promoter. Binds to the MYC promoter. Requires the 5'-TAATTA-3' consensus sequence for DNA-binding

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.